13th International Congress
THE "NEW FRONTIERS"
OF ARRHYTHMIAS 1998

January 24-31, 1998
Marilleva, Trento, Italy

RT-104

Heart rate variability and signal averaged ECG as predictors of clinical outcome in patients with acute myocardial infarction

Maria Stella Fera, Alessandro Carunchio, Andrea Mazza, Maurizio Burattini, Maria Margherita Matinelli, Vincenzo Ceci.
Division of Cardiology, S. Spirito Hospital, Rome, Italy

Introduction

Patients surviving acute myocardial infarction are susceptible to heart failure, recurrence of angina, reinfarction, arrhythmias and sudden cardiac death. Most deaths and heart failure occur in the first six months after infarction. Analysis of heart rate variability (HRV) has provided a noninvasive method for assessing autonomic influence on the heart. The predictive value of depressed heart rate variability after myocardial infarction has been shown to be independent of other risk factors, such as left ventricular ejection fraction, frequency of ventricular premature complexes on the 24-h Holter recording and the presence of late potentials on signal-averaged electrocardiogram. Decrease HRV has been found to be nearly as powerful as a decrease in left ventricular ejection fraction to predict total cardiac mortality1. Late potentials, detected by use of the signal-averaged ECG (SAECG), suggest the presence of slow conduction. The presence of an abnormal SAECG, after myo-cardial infarction, portends a significantly increased risk for arrhythmic events. However, data of the predictive values of SAECG for total cardiac mortality in post-infarction risk stratification are contrasting. The influence of the type of contractile disturbances and the extent of coronary artery lesions on SAECG remains unclear. Uncertain is the role of HRV and SAECG in relation to the clinical deterioration in patients with myocardial infarction and the correlation of these parameters with the develop of heart failure and ischemic recurrences. The aim of this study was to evaluate the prognostic value of HRV and SAECG for clinical deterioration (progressive heart failure and ischemic recurrences) during the first year of follow-up after acute myocardial infarction.

 

backward

forward

CARDIOnet® - registered trade mark name
Copyright © 1996-1998 by CARDIOnet. All rights reserved.